Lawmakers Urge FDA To Rethink Drug Labeling
A group of lawmakers has asked the U.S. Food and Drug Administration to reconsider a proposed rule regarding drug labeling, saying it was designed to shield pharmaceutical and device companies from...To view the full article, register now.
Already a subscriber? Click here to view full article